Literature DB >> 24229634

Rosacea: current state of epidemiology.

Jerry Tan1, Mats Berg.   

Abstract

Case definitions are critical in epidemiologic research. However, modern disease indicators must now consider complex data from gene-based research along with traditional clinical parameters. Rosacea is a skin disorder with multiple signs and symptoms. In individuals, these features may be multiple or one may predominate. While studies on the epidemiology of rosacea have previously been sparse, there has been a recent increase in research activity. A broader body of epidemiological information that includes a greater variety of countries beyond Northern Europe and general population-based demographics is needed. As there are operational issues in current case definitions of rosacea subtypes--rationalization and standardization--universal consistent applications in future research is also imperative. Further improvement in disease definition combining new research information along with clinical pragmatism should increase the accuracy of rosacea case ascertainment and facilitate further epidemiological research.
Copyright © 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  CI; GST; NRSEC; National Rosacea Society Expert Committee; OR; UV; comorbidities; confidence interval; epidemiology; glutathione S-transferase; odds ratio; prevalence; risk factors; rosacea; subtype; ultraviolet

Mesh:

Year:  2013        PMID: 24229634     DOI: 10.1016/j.jaad.2013.04.043

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  38 in total

Review 1.  Rosacea: new and emerging treatments.

Authors:  Farah A Moustafa; Laura F Sandoval; Steven R Feldman
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

2.  Rosacea, Use of Tetracycline, and Risk of Incident Inflammatory Bowel Disease in Women.

Authors:  Wen-Qing Li; Eunyoung Cho; Hamed Khalili; Shaowei Wu; Andrew T Chan; Abrar A Qureshi
Journal:  Clin Gastroenterol Hepatol       Date:  2015-09-25       Impact factor: 11.382

Review 3.  Flushing Disorders Associated with Gastrointestinal Symptoms: Part 2, Systemic Miscellaneous Conditions.

Authors:  Vaibhav Rastogi; Devina Singh; Joseph J Mazza; Dipendra Parajuli; Steven H Yale
Journal:  Clin Med Res       Date:  2018-04-12

4.  Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).

Authors:  James Q Del Rosso; Emil Tanghetti; Guy Webster; Linda Stein Gold; Diane Thiboutot; Richard L Gallo
Journal:  J Clin Aesthet Dermatol       Date:  2020-06-01

5.  Augmented supraorbital skin sympathetic nerve activity responses to symptom trigger events in rosacea patients.

Authors:  Kristen Metzler-Wilson; Kumika Toma; Dawn L Sammons; Sarah Mann; Andrew J Jurovcik; Olga Demidova; Thad E Wilson
Journal:  J Neurophysiol       Date:  2015-07-01       Impact factor: 2.714

6.  Photodynamic therapy for rosacea in Chinese patients.

Authors:  Lili Fan; Rui Yin; Ting Lan; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2018-08-15       Impact factor: 3.631

7.  Biophotonic Therapy with Fluorescent Light Energy Decreases Facial Erythema, Improves Signs and Symptoms of Rosacea, and Increases Patient Satisfaction: A Postmarket Study.

Authors:  Martin Wade; Vanessa Charest; Bruno Ballardin; Deirdre Edge; Michael Canova Engelbrecht Nielsen
Journal:  J Clin Aesthet Dermatol       Date:  2021-07-01

Review 8.  Interventions for rosacea.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Ben Carter; Mireille M D van der Linden; Lyn Charland
Journal:  Cochrane Database Syst Rev       Date:  2015-04-28

9.  Rosacea: New Concepts in Classification and Treatment.

Authors:  Esther J van Zuuren; Bernd W M Arents; Mireille M D van der Linden; Sofieke Vermeulen; Zbys Fedorowicz; Jerry Tan
Journal:  Am J Clin Dermatol       Date:  2021-03-23       Impact factor: 7.403

10.  Personal history of rosacea and risk of incident cancer among women in the US.

Authors:  W-Q Li; M Zhang; F W Danby; J Han; A A Qureshi
Journal:  Br J Cancer       Date:  2015-06-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.